CA Patent

CA2846574C — Quinoxaline sulfonamide derivates for use as kinase inhibitors

Assigned to Neupharma Inc · Expires 2020-07-07 · 6y expired

What this patent protects

The present disclosure provides benzenesulfonamide derivatives of quinoxaline, represented by Formula I, that are kinase inhibitors, pharmaceutical compositions thereof, and uses thereof in treating cancer. (see formula I)

USPTO Abstract

The present disclosure provides benzenesulfonamide derivatives of quinoxaline, represented by Formula I, that are kinase inhibitors, pharmaceutical compositions thereof, and uses thereof in treating cancer. (see formula I)

Drugs covered by this patent

Patent Metadata

Patent number
CA2846574C
Jurisdiction
CA
Classification
—
Expires
2020-07-07
Drug substance claim
No
Drug product claim
No
Assignee
Neupharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.